TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today published a roundup of seven comments from clinicians and researchers on developments discussed in medical reporting during the week of Oct. 25, 2026. The comments span dengue outbreaks, pregnancy exposure to dupilumab, menopause treatments, advance care planning and early-stage research; the roundup does not establish new clinical guidance.
MedPage Today published a weekly roundup on October 25, 2026, collecting seven comments from clinicians and researchers about medical developments covered by its reporters. The remarks touch on dengue outbreaks, pregnancy and medication exposure, menopause symptoms, diagnostic errors, care planning and preliminary research, but the collection is a recap rather than a new clinical study or policy announcement.
One quote concerned dengue. Adam Waickman, a researcher at SUNY Upstate Medical University, said, “The cat is out of the bag” while discussing large outbreaks in Florida and warning of possible further spread across the United States. The roundup provides no case counts, locations beyond Florida, or forecast details to quantify that risk.
Other comments addressed questions about treatment and diagnosis. Christina Chambers of the University of California San Diego called it “an open question” whether early-life exposure to dupilumab, also known as Dupixent, might affect a child’s longer-term risk of atopic conditions; the source says pregnancy exposure appeared safe in the data discussed, but does not supply study details. Marisa McGinley of the Cleveland Clinic said incorrect multiple sclerosis diagnoses do occur, in reference to actress Christina Applegate’s diagnosis.
The remaining remarks covered a reported, exceptionally rare case in which an infant initially treated for constipation was later found to have a second colon; a meta-analysis on non-hormonal menopause drugs and sleep disturbances; a video decision-support tool associated with increased advance care planning documentation among patients nearing kidney failure; and a small trial linking psilocybin with reduced markers of systemic inflammation and mitochondrial stress in people with Parkinson’s disease. The roundup gives no full study methods or results for these items.
Seven Topics, Different Evidence
The roundup brings together issues with different levels of evidence and different implications. A warning about potential dengue spread concerns public health monitoring, while questions about drug exposure in pregnancy and a small trial of psilocybin concern research that requires detailed study data before readers can judge its significance.
Its value is as a snapshot of subjects clinicians and researchers discussed during the week, not as a substitute for the underlying reporting. The comments may flag areas where further research or attention is warranted, but quotes alone do not establish safety, effectiveness, frequency or causation. Readers seeking practical medical information would need the full studies and guidance from qualified health professionals.
Products Worth Considering
Bowflex PR1000 Home Gym
Levoit Eleva 300X HEPA Air Purifier for Home and Bedroom
Oura Ring 5 Smart Ring, Silver, Size 10
As an affiliate, we earn on qualifying purchases.
The Weekly Quotes Roundup
MedPage Today’s “What We Heard This Week” format presents quotable comments from its reporters’ coverage, rather than a single developing event. The October 25 edition includes seven speakers affiliated with hospitals, universities and research institutions in the United States and England.
The source identifies the topics but offers only brief descriptions of the underlying reports. It does not provide publication dates for the cited studies, participant numbers beyond describing one trial as small, or enough methodological detail to compare findings. The article should therefore be read as a collection of attributed remarks, with the underlying evidence requiring separate review.
““This is good news for women.””
— JoAnn Manson, MD, MPH, DrPH, Harvard Medical School
Evidence Behind the Brief Remarks
The roundup does not identify the full methods, sample sizes, effect estimates or limitations for most of the studies and reports it mentions. It also does not give dengue case counts or explain the evidence behind the warning about further spread. Those omissions mean the comments cannot establish how large or generalizable the reported effects are.
For the dupilumab discussion, the source says pregnancy exposure appeared safe in the data described, but does not provide enough information to assess the population or follow-up. The long-term question about children’s atopic conditions remains unresolved. The psilocybin finding is described as coming from a small trial and concerns biological markers; the source does not say that it showed clinical improvement in Parkinson’s disease.
Full Reports Will Add Detail
The next step for readers is to consult the underlying MedPage Today reports and original research for study designs, findings and limitations. The source does not announce a specific follow-up date, new public-health measure or change in clinical guidance.
Further evidence would be needed to clarify the longer-term implications of early-life dupilumab exposure and the clinical meaning of the small psilocybin trial. The dengue outlook also depends on surveillance and updates from public-health authorities; the roundup does not give a timetable or forecast.
Key Questions
What did MedPage Today publish?
It published a weekly roundup of seven medical quotes on October 25, 2026, covering topics from dengue to treatment research and care planning.
Does the roundup announce new medical guidance?
No. It collects comments about reported developments and does not announce new clinical guidance or policy.
What did the dengue comment refer to?
Adam Waickman was discussing large dengue outbreaks in Florida and the possibility of further spread across the United States. The roundup does not give case counts or a detailed forecast.
Did the dupilumab discussion settle whether exposure affects children later?
No. Christina Chambers described the long-term effect as an open question. The roundup says pregnancy exposure appeared safe in the data discussed but provides no study details.
Did the psilocybin trial show that the drug treats Parkinson’s disease?
The source describes a small trial linking psilocybin with lower markers of inflammation and mitochondrial stress. It does not report that the trial established clinical benefit or treatment effectiveness.
Source: rss
